发明名称 ANTI-CANCER THERAPEUTIC STRATEGY TO OVERCOME CANCER RESISTANCE AND TO ENABLE TAILORING TREATMENT TO PATIENTS
摘要 A gene construct comprising a programmed-cell-death executioner gene having a nuclear localization signal, a deleted signal peptide, an actin-resistant binding site, a promoter, and an activator. A method of making a gene construct, by modifying a programmed-cell-death executioner gene by adding a nuclear localization signal, deleting a signal peptide, mutating a binding site for an inhibitor to make it actin- resistant, adding a promoter for exclusive expression in selected cells, and adding an activator. A method of eliminating undesired cells from a patient. A method of treating cancer. An array comprising at least two gene constructs each having different killer genes at their core and different nuclear localization signals. A method of personalizing anti-cancer treatment. A method of increasing DNase 1 resistance to actin binding. A method of increasing catalytic activity of DNase 1 binding.
申请公布号 WO2011031467(A1) 申请公布日期 2011.03.17
申请号 WO2010US46588 申请日期 2010.08.25
申请人 WAYNE STATE UNIVERSITY;ROSNER, KARLI 发明人 ROSNER, KARLI
分类号 C12N15/00 主分类号 C12N15/00
代理机构 代理人
主权项
地址